FindTrial
Sign In

Effect Of Vidanga Tandula Rasayana On Immunity

STUDY ON IMMUNOMODULATORY EFFECT OF VIDANGA TANDULA RASAYANA (An experimental and single blind randomized placebo-controlled clinical trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040963
Enrollment
100
Registered
2022-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)subjects of either sex will be screened for ISQ less than 6 b)willing to participate in the study c)patients having no allergic history to herbal medicines or particularly to any ingredient of Vidanga tandula rasayana

Exclusion criteria

Exclusion criteria: a) ISQ final score equal to or more than 6 b)not willing to participate in the study c)Diagnosed case of HIV and Diabetes mellitus d)During pregnancy and lactation e)patients with chronic illness on regular medications f)subjects having participated in other clinical trial within 3 months before recruitment g)evidence of significant uncontrolled concomitant disease which in the investigators opinion would preclude patient participation

Design outcomes

Primary

MeasureTime frame
ISQ, IgG, IgE, IgM, IL4 and IL5 levelsTimepoint: baseline and 4 weeks—

Secondary

MeasureTime frame
status of ojas, agnibala, dehabala and satva bala. WHO QOL-BREFTimepoint: 0th , 15th, 30th and 60th day—

Countries

India

Contacts

Public ContactDr Bhargav Bhide

ALL INDIA INSTITUTE OF AYURVEDA, NEW DELHI

tnesari@hotmail.com9958817145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026